Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report.

Case reports in women's health

Chae-Kim JJ, Roman R, Hawkins K, Gavrilova-Jordan L.
PMID: 34159057
Case Rep Womens Health. 2021 Jun 04;31:e00332. doi: 10.1016/j.crwh.2021.e00332. eCollection 2021 Jul.

Ovarian hyperstimulation syndrome (OHSS) is a feared complication of controlled ovarian stimulation (COS) and can be associated with significant morbidity and mortality. Risk factors for OHSS include a history of OHSS, young age, low body mass index (BMI), polycystic...

Cite
Chae-Kim JJ, Roman R, Hawkins K, et al. Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report. Case Rep Womens Health. 2021;31:e00332doi: 10.1016/j.crwh.2021.e00332.
Chae-Kim, J. J., Roman, R., Hawkins, K., & Gavrilova-Jordan, L. (2021). Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report. Case reports in women's health, 31e00332. https://doi.org/10.1016/j.crwh.2021.e00332
Chae-Kim, Jennifer J, et al. "Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report." Case reports in women's health vol. 31 (2021): e00332. doi: https://doi.org/10.1016/j.crwh.2021.e00332
Chae-Kim JJ, Roman R, Hawkins K, Gavrilova-Jordan L. Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report. Case Rep Womens Health. 2021 Jun 04;31:e00332. doi: 10.1016/j.crwh.2021.e00332. eCollection 2021 Jul. PMID: 34159057; PMCID: PMC8196041.
Copy Download .nbib Format: NLM
Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies.

Biomedicines

Chae-Kim JJ, Gavrilova-Jordan L.
PMID: 30597834
Biomedicines. 2018 Dec 28;7(1). doi: 10.3390/biomedicines7010002.

Premature ovarian insufficiency (POI) is the loss of normal hormonal and reproductive function of ovaries in women before age 40 as the result of premature depletion of oocytes. The incidence of POI increases with age in reproductive-aged women, and...

Cite
Chae-Kim JJ, Gavrilova-Jordan L. Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies. Biomedicines. 2018;7(1)doi: 10.3390/biomedicines7010002.
Chae-Kim, J. J., & Gavrilova-Jordan, L. (2018). Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies. Biomedicines, 7(1), . https://doi.org/10.3390/biomedicines7010002
Chae-Kim, Jennifer J, and Gavrilova-Jordan, Larisa. "Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies." Biomedicines vol. 7,1 (2018). doi: https://doi.org/10.3390/biomedicines7010002
Chae-Kim JJ, Gavrilova-Jordan L. Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies. Biomedicines. 2018 Dec 28;7(1). doi: 10.3390/biomedicines7010002. PMID: 30597834; PMCID: PMC6466184.
Copy Download .nbib Format: NLM
Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility.

Biomedicines

Mikhael S, Punjala-Patel A, Gavrilova-Jordan L.
PMID: 30621143
Biomedicines. 2019 Jan 04;7(1). doi: 10.3390/biomedicines7010005.

The hypothalamic-pituitary-ovarian (HPO) axis is a tightly regulated system controlling female reproduction. HPO axis dysfunction leading to ovulation disorders can be classified into three categories defined by the World Health Organization (WHO). Group I ovulation disorders involve hypothalamic failure...

Cite
Mikhael S, Punjala-Patel A, Gavrilova-Jordan L. Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility. Biomedicines. 2019;7(1)doi: 10.3390/biomedicines7010005.
Mikhael, S., Punjala-Patel, A., & Gavrilova-Jordan, L. (2019). Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility. Biomedicines, 7(1), . https://doi.org/10.3390/biomedicines7010005
Mikhael, Sasha, et al. "Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility." Biomedicines vol. 7,1 (2019). doi: https://doi.org/10.3390/biomedicines7010005
Mikhael S, Punjala-Patel A, Gavrilova-Jordan L. Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility. Biomedicines. 2019 Jan 04;7(1). doi: 10.3390/biomedicines7010005. PMID: 30621143; PMCID: PMC6466056.
Copy Download .nbib Format: NLM
Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Chae-Kim J, Garg G, Gavrilova-Jordan L, Blake LE, Kim TT, Wu Q, Hayslip CC.
PMID: 34785524
Int J Gynecol Cancer. 2021 Dec;31(12):1499-1505. doi: 10.1136/ijgc-2021-002699. Epub 2021 Nov 16.

OBJECTIVE: Progestin therapy is the recommended fertility-sparing management of atypical endometrial hyperplasia or early-stage endometrial cancer in reproductive-aged women. Our objective was to evaluate disease relapse after progestin and metformin versus progestin therapy alone in patients with endometrial hyperplasia...

Cite
Chae-Kim J, Garg G, Gavrilova-Jordan L, et al. Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2021;31(12):1499-1505doi: 10.1136/ijgc-2021-002699.
Chae-Kim, J., Garg, G., Gavrilova-Jordan, L., Blake, L. E., Kim, T. T., Wu, Q., & Hayslip, C. C. (2021). Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 31(12), 1499-1505. https://doi.org/10.1136/ijgc-2021-002699
Chae-Kim, Jennifer, et al. "Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 31,12 (2021): 1499-1505. doi: https://doi.org/10.1136/ijgc-2021-002699
Chae-Kim J, Garg G, Gavrilova-Jordan L, Blake LE, Kim TT, Wu Q, Hayslip CC. Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2021 Dec;31(12):1499-1505. doi: 10.1136/ijgc-2021-002699. Epub 2021 Nov 16. PMID: 34785524.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries